Antioxidant enzyme and malondialdehyde levels in patients with panic disorder

被引:109
|
作者
Kuloglu, M
Atmaca, M
Tezcan, E
Ustundag, B
Bulut, S
机构
[1] Firat Univ, Fac Med, Dept Psychiat, Elazig, Turkey
[2] Firat Univ, Fac Med, Dept Biochem, Elazig, Turkey
[3] Firat Univ, Fac Med, Dept Neurol, Elazig, Turkey
关键词
panic disorder; antioxidant enzyme; malondialdehye;
D O I
10.1159/000067810
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
There is evidence of an etiopathogenetic role of free radicals (FRs) in some neuropsychiatric disorders. The aim of the present study was to determine whether the activity levels of some antioxidant enzymes [glutathione peroxidase (GSH-Px), superoxide dismutase (SOD) and catalase (CAT)] and malondialdehyde (MDA), a product of lipid peroxidation, were associated with panic disorder (PD). Twenty patients diagnosed with PD and 20 healthy controls were enrolled in this study. A clinical evaluation and measurements of GSH-Px SOD, CAT and MDA were performed. Additionally, all patients were assessed by the Panic Agoraphobia Scale (PAS). The mean GSH-Px, SOD and MDA levels of the patient group were significantly higher than those of the controls. There was a significant positive correlation between PAS scores and GSH-Px, SOD and MDA levels and between the duration of illness and SOD, CAT and MDA levels in the patient group. In conclusion, our results suggest that FRs may be involved in PD. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:186 / 189
页数:4
相关论文
共 50 条
  • [1] Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder
    Kuloglu, M
    Atmaca, M
    Tezcan, E
    Gecici, Ö
    Tunckol, H
    Ustundag, B
    NEUROPSYCHOBIOLOGY, 2002, 46 (01) : 27 - 32
  • [2] Antioxidant enzyme and malondialdehyde levels in patients with social phobia
    Atmaca, Murad
    Kuloglu, Murat
    Tezca, Ertan
    Ustundag, Bilal
    PSYCHIATRY RESEARCH, 2008, 159 (1-2) : 95 - 100
  • [3] Serum selenium and plasma malondialdehyde levels and antioxidant enzyme activities in patients with obsessive-compulsive disorder
    Ozdemir, Ercan
    Cetinkaya, Sevil
    Ersan, Serpil
    Kucukosman, Seda
    Ersan, E. Erdal
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2009, 33 (01): : 62 - 65
  • [4] Antioxidant enzyme activities and malondialdehyde levels related to aging
    Inal, ME
    Kanbak, G
    Sunal, E
    CLINICA CHIMICA ACTA, 2001, 305 (1-2) : 75 - 80
  • [5] Levels of plasma malondialdehyde and erythrocyte antioxidant enzyme activities in patients with chronic hepatitis B
    Demirdag, K
    Yilmaz, S
    Ozdarendeli, A
    Ozden, M
    Kalkan, A
    Kilic, SS
    HEPATO-GASTROENTEROLOGY, 2003, 50 (51) : 766 - 770
  • [6] Immunoglobulin levels in panic disorder patients
    Nahar, Zabun
    Khanum, Sayema
    Harun, Saima
    Islam, Sheikh Nazrul
    Sobhan, Md. Abdus
    Islam, Md Saiful
    Hasnat, Abul
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 25 (01) : 149 - 153
  • [7] Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder
    Kuloglu, M
    Ustundag, B
    Atmaca, M
    Canatan, H
    Tezcan, AE
    Cinkilinc, N
    CELL BIOCHEMISTRY AND FUNCTION, 2002, 20 (02) : 171 - 175
  • [8] HIGH CHOLESTEROL LEVELS IN PATIENTS WITH PANIC DISORDER
    BAJWA, WK
    ASNIS, GM
    SANDERSON, WC
    IRFAN, A
    VANPRAAG, HM
    AMERICAN JOURNAL OF PSYCHIATRY, 1992, 149 (03): : 376 - 378
  • [9] HIGH CHOLESTEROL LEVELS IN PATIENTS WITH PANIC DISORDER
    FEDER, R
    AMERICAN JOURNAL OF PSYCHIATRY, 1993, 150 (03): : 527 - 527
  • [10] Blood endocannabinoid levels in patients with panic disorder
    Petrowski, Katja
    Kirschbaum, Clemens
    Gao, Wei
    Hardt, Jochen
    Conrad, Rupert
    PSYCHONEUROENDOCRINOLOGY, 2020, 122